VFP
CORT icon

Vilga Financial Planning’s Corcept Therapeutics CORT Stock Holding History

Vilga Financial Planning’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.5M Buy
+13,046
New +$1.4M 0.9% 26

Other funds holding CORT

GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return
BCG
Breakwater Capital Group Paramus, New Jersey $844M AUM 15.36% 1-Year Est. Return
RA
Riversedge Advisors Wilmington, Delaware $813M AUM 18.09% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
EWP
Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return

Vilga Financial Planning's CORT Position: Q3 2026 in Review

Vilga Financial Planning opened a new position in Corcept Therapeutics (CORT) in Q3 2026: 13,046 shares worth $1.5M. The stake represents 0.9% of the portfolio and ranks #26 among its holdings.

12 funds tracked by Wall St. Rank hold CORT as of Q3 2026.

  • Vilga Financial Planning held 13,046 shares of Corcept Therapeutics worth $1.5M as of Q3 2026.
  • Corcept Therapeutics was a new Vilga Financial Planning position in Q3 2026.
  • Corcept Therapeutics made up 0.9% of Vilga Financial Planning's portfolio in Q3 2026, its #26 holding.
  • 12 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2026.

Based on Vilga Financial Planning's 13F filing for Q3 2026, filed 9 Oct 2026.